Acta Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, published by Taylor & Francis Ltd, is a distinguished scholarly journal dedicated to the exploration of biomaterials and their applications in various fields such as bioengineering, biomedical engineering, and biophysics. With an ISSN of 0920-5063 and an E-ISSN of 1568-5624, this journal offers a platform for researchers and professionals to share innovative findings and methodologies that advance the science of polymer-based biomaterials. The journal's impact within the academic community is underscored by its notable Scopus rankings, including a Q2 status in both Biomedical Engineering and Biophysics as of 2023, reflecting its significant contribution to advancing knowledge and practice in these fields. The scope of the journal spans from fundamental research to applications in medical devices and regenerative medicine, ensuring comprehensive coverage of the latest trends and breakthroughs. Although it does not currently offer open access options, the journal remains a pivotal resource for students, researchers, and professionals committed to the development and application of biomaterials in healthcare. For further details, the journal is based in Abingdon, United Kingdom, at 2-4 Park Square, Milton Park, OX14 4RN.

Bioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.

Gels is a distinguished, peer-reviewed journal published by MDPI, focusing on the innovative field of gels and their myriad applications across disciplines such as bioengineering, biomaterials, and organic chemistry. Since its inception in 2015, this Open Access journal has provided a platform for researchers to disseminate cutting-edge findings, enabling wider visibility and impact for their work. Based in Switzerland, Gels has firmly established itself within the academic community, achieving notable recognition as evidenced by its recent Q1 ranking in Polymers and Plastics, and multiple Q2 placements in related categories, demonstrating its relevance and importance in the field. The journal serves as a vital resource for professionals and scholars aiming to engage with the rapidly evolving research landscape surrounding gel technologies, making significant contributions to sustainable materials, drug delivery systems, and much more. With its commitment to Open Access, Gels ensures that research findings are readily accessible to all stakeholders, fostering collaboration and advancement in science and engineering fields.

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

Biomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.

VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.

Regenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.